COMMUNIQUÉS West-GlobeNewswire

Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation
30/10/2026
Speaking at the Asia-Pacific Conference of German Business in Seoul, Boehringer Ingelheim Chairman of the Board of Managing Directors, Shashank Deshpande, highlights the region’s growing role Boehringer builds on its [...]
Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques
30/10/2026
Le TGM-148 est conçu pour associer une efficacité hémostatique à un profil de sécurité favorable et une faible contrainte thérapeutique Le deuxième actif de Tangram à entrer en phase clinique en 2026 L’essai de phase 1 [...]
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
30/10/2026
This international award, honoring “the best of the best” in medical innovation, represents yet another important external recognition of AI-Immunology™ COPENHAGEN, Denmark, October 30, 2026 - Evaxion A/S (NASDAQ: EVAX [...]
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026
30/10/2026
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026 Halle (Saale) / Munich, Germany, October 30, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a [...]
Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health
30/10/2026
SHANGHAI, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, received the “Digital-intelligence Leadership Award- [...]
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026
30/10/2026
Tokyo, Japan and Cambridge, UK, 30 October 202 6 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third quarter ended 30 [...]
Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded
30/10/2026
Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded October 30, 2026 Q3 sales growth of 14.3% at CER 1 and business earnings per share (EPS) 2 of €3.55 Pharma launches sales increased by 31 [...]
Communiqué de presse : T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026
30/10/2026
T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026 Paris, le 30 octobre 2026 Ventes du T3 en progression de 14,3 % à TCC 1 et BNPA 2 des activités de 3,55 [...]
Nicox Reports First Half 2026 Financial Results
30/10/2026
Press Release Nicox Reports First Half 2026 Financial Results Revenue increased to €3.5 million compared to €1.5 million in H1 2025 Net loss decreased to €0.5 million from €8.9 million in H1 2025 Cash and cash [...]
Nicox publie les résultats financiers du premier semestre 2026
30/10/2026
Communiqué de presse Nicox publie les résultats financiers du premier semestre 2026 Chiffre d’affaires de 3,5 millions d’euros contre 1,5 million d’euros au premier semestre 2025 Perte nette réduite à 0,5 million d’ [...]
Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein
30/10/2026
Dual-Target Approach Designed to Modulate Both Innate and Adaptive Immunity Advances Into Clinical Evaluation in Patients With SLE NANJING, China, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (" [...]
2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation
30/10/2026
PALO ALTO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Following the awarding of the 2026 Nobel Prize in Physiology or Medicine to pioneers in optogenetics, the InLight Foundation concluded its "Consciousness and Science [...]
Aspen Neuroscience Announces Pricing of Initial Public Offering
30/10/2026
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Aspen Neuroscience, Inc. (Nasdaq: ASPE), a clinical-stage regenerative medicine biotechnology company developing autologous cell therapies for Parkinson’s disease (PD), today [...]
InnoCare Announces First Subject Dosed in Clinical Trial of TL1A/IL-23p19 Bispecific Antibody ICP-B161 in China
30/10/2026
BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
29/10/2026
SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units
29/10/2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Oct. 29 [...]
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
29/10/2026
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
29/10/2026
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
29/10/2026
IRVINE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 3, 2026 to report its [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum